Amgen Inc
Change company Symbol lookup
Select an option...
AMGN Amgen Inc
SOPA Society Pass Inc
GMDA Gamida Cell Ltd
TITN Titan Machinery Inc
GEL Genesis Energy LP
TTWO Take-Two Interactive Software Inc
BZUN Baozun Inc
COMSW ComSovereign Holding Equity Warrants Exp 18th Dec 2025 *W EXP 12/18/2025
DYN Dyne Therapeutics Inc
C-K Citigroup Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Postmarket

Last Trade
Delayed
$233.97
0.87 (0.37%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$233.10
Day's Change
3.27 (1.42%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
234.10
Day's Low
229.89
Volume
(Light)
Volume:
2,175,637

10-day average volume:
2,988,269
2,175,637
  • Prev Close
    229.83
  • Today's Open
    230.04
  • Day's Range
    229.89-234.10
  • Avg Vol (10-day)
    3.0M
  • Last (time)
    4:00p ET 03/23/23
  • Last (size)
    100
  • 52-Wk Range
    223.30 - 296.67
    LowHigh
  • (09/22/22 - 11/08/22)
    4.39%
  • 20.7%
  • Market Cap
    124.5B
  • Shares Outstanding
    534.0M
  • 12.12
  • 19.22x
  • $8.52/3.71%
  • Ex-dividend Date
    05/17/23
  • Dividend Pay Date
    06/08/23
  • 0.6
  • 75.99
  • (% of float 02/28/23)
    1.38

Latest News

March 23, 2023
7:38 pm ET
Newsfile
7:16 pm ET
Newsfile
4:37 pm ET
MarketWatch
1:59 pm ET
Newsfile
12:31 pm ET
Newsfile
11:36 am ET
Accesswire
11:01 am ET
Accesswire
9:29 am ET
Newsfile
5:45 am ET
PR Newswire
March 22, 2023
9:34 pm ET
Accesswire
9:00 pm ET
Globe Newswire
6:21 pm ET
Accesswire
5:50 pm ET
PR Newswire
4:37 pm ET
MarketWatch
1:11 pm ET
Newsfile
12:33 pm ET
BusinessWire
10:15 am ET
Globe Newswire
9:28 am ET
Newsfile
5:45 am ET
PR Newswire
1:45 am ET
PR Newswire
March 21, 2023
9:34 pm ET
Accesswire
4:37 pm ET
MarketWatch
1:14 pm ET
BusinessWire
12:33 pm ET
Accesswire
11:09 am ET
Newsfile
11:02 am ET
Accesswire
10:53 am ET
Accesswire
9:30 am ET
BusinessWire
9:27 am ET
Newsfile
5:45 am ET
PR Newswire
March 20, 2023
7:24 pm ET
Accesswire
7:19 pm ET
Newsfile
5:56 pm ET
Newsfile
5:53 pm ET
Globe Newswire
5:53 pm ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.